Intracranial Pressure (ICP) Monitoring Market

Intracranial Pressure (ICP) Monitoring Market Overview (2024 to 2034)

In 2024, the global intracranial pressure (ICP) monitoring market is estimated to be worth US$ 251.5 million. The market's CAGR is projected to be 5.0% from 2024 to 2034. The market is predicted to grow and reach a value of US$ 410.4 million by 2034.

The intracranial pressure (ICP) monitoring market is experiencing growth due to various factors. One of the main reasons is the increasing incidence of traumatic brain injuries (TBIs) and neurological disorders. As the aging population rises, neurological disorders such as Alzheimer's disease and Parkinson's disease are becoming more prevalent, leading to higher demand for ICP monitoring devices.

Advancements in technology, such as the development of non-invasive ICP monitoring systems, are expected to drive the growth of the market. The rising demand for ICP monitoring devices in developing countries due to improved healthcare infrastructure and awareness is also a key factor contributing to the market's growth.

In recent years, there has been a shift toward the development of non-invasive ICP monitoring devices, which are less painful and risky compared to traditional invasive methods. This has further fueled the demand for ICP monitoring devices in the healthcare industry. Additionally, the increasing investments in research and development activities by key players to develop innovative products and expand their product portfolios are also expected to drive the growth of the market over the coming years.

The high cost of these devices and the lack of awareness among patients about the benefits of ICP monitoring are some of the factors that are expected to hinder the growth of the market. Overall, the global ICP monitoring market is expected to witness significant growth in the foreseeable future, driven by technological advancements and increasing demand for better healthcare services.

Key Market Growth Drivers

The increasing prevalence of neurological disorders such as traumatic brain injury is expected to fuel market expansion. The rising incidence of malnutrition around the world is projected to create significant opportunities for the market.

Report Attributes	Details
Estimated Market Value (2024E)	US$ 251.5 million
Forecasted Market Value (2034F)	US$ 410.4 million
Global Market Growth Rate (2024 to 2034)	5.0% CAGR
ICP Monitoring Segment Growth Rate (2024 to 2034)	5.1%CAGR
North America Market Share (2024)	58.4%
East Asia Market Share (2024)	15.4%
Key Companies Profiled	Sophysa Ltd. Spiegelberg Integra LifeSciences HeadSense Medical Medtronic Raumedic Johnson and Johnson Vittamed

Which Factors are Boosting the Demand for Intracranial Pressure (ICP) Monitoring?

“Rising Prevalence of Neurological Disorders Such As Traumatic Brain Injury”

The intracranial pressure monitoring market is witnessing significant growth due to the increasing prevalence of neurological disorders such as traumatic brain injuries, strokes, and brain tumors. These disorders can lead to an increase in intracranial pressure (ICP), which can cause severe brain damage or even death. Therefore, the monitoring of ICP is crucial in the management of these disorders.

Rising geriatric population is also contributing to the growth of this market. As people age, they become more susceptible to neurological disorders and other health complications, which can lead to an increase in ICP. Therefore, the demand for intracranial pressure monitoring is expected to increase significantly in the coming years.

“Increasing Geriatric Population and Neurological Conditions”

Non-invasive methods for intracranial pressure (ICP) monitoring are becoming increasingly popular due to their several advantages over invasive methods. Non-invasive methods are safer, less painful, and less prone to complications, making them more desirable for patients and healthcare professionals.

Increasing prevalence of neurological disorders and the rising geriatric population are also expected to contribute to the growth of the intracranial pressure monitoring market. As the incidence of neurological disorders increases, the demand for ICP monitoring devices is expected to rise, creating opportunities for market players to innovate and develop new products.

What is Hindering the Growth of the Intracranial Pressure (ICP) Monitoring Market?

“High Cost of Equipment and a Lack of Trained Professionals”

Intracranial pressure monitoring involves measuring the pressure inside the skull, which is important for the diagnosis and management of various neurological conditions. However, the cost of the equipment and the need for trained professionals to perform the procedure can be a barrier to widespread adoption. This can limit access to the technology, especially in areas with limited healthcare resources or where the costs are not covered by insurance. Additionally, the lack of trained professionals can lead to errors or inaccuracies in monitoring, which can have serious consequences for patient outcomes.

Country-wise Insights

In line with expanding regional sales, the intracranial pressure (ICP) monitoring market finds most of its consumer base in North America and East Asia. In 2024, North America is estimated to account for 58.4% of the global market. From 2024 to 2034, the region's market is expected to rise at a moderate CAGR of 5.4% and hold a share of 60.5% by the end of 2034.

East Asia is expected to account for a significant share of the market. In 2024, East Asia's market share is predicted to be 15.4%. During the projection period, East Asia's market is expected to grow at a 4.4% CAGR, with the region retaining a 14.5% share by the end of the forecast period.

Regions	CAGR (2024 to 2034)
North America	5.4%
East Asia	4.4%

What is Contributing to the Growth of the United States Intracranial Pressure (ICP) Monitoring Market?

“Rising Demand for Less Invasive Surgeries for Neurological Ailments”

The value of the intracranial pressure (ICP) monitoring industry in the United States is estimated to be US$ 140 million in 2024. The market is expected to register a CAGR of 5.4% and reach a value of US$ 239 million by 2034.

In the United States, the market for intracranial pressure monitoring is expected to grow significantly due to the rising demand for less invasive surgeries and the increasing prevalence of neurological disorders. The country has a well-established healthcare infrastructure, and the adoption of advanced healthcare technologies is high, driving the market.

The increasing geriatric population in the United States is also fueling the growth of the intracranial pressure monitoring market. As people age, they become more susceptible to neurological disorders and other health complications, which can lead to an increase in ICP. Therefore, the demand for intracranial pressure monitoring is expected to increase significantly in the coming years.

Why is China Emerging as a Lucrative Market for Intracranial Pressure (ICP) Monitoring?

“Increasing Healthcare Spending in China”

China is a rapidly growing market for intracranial pressure monitoring. The country's large population, increasing healthcare spending, and rising prevalence of neurological disorders are driving the growth of this market. In addition, the growing popularity of sports and outdoor activities is also contributing to the demand for intracranial pressure monitoring in China.

Sports injuries are becoming increasingly common in China, particularly among young people. The country has a large population of young athletes who participate in a wide range of sports, including football, basketball, and martial arts. As a result, the demand for intracranial pressure monitoring devices is increasing, as these devices are essential for the diagnosis and management of sports-related head injuries.

Category-wise Insights

Based on the end user, the hospital segment is expected to account for 29.4% of the market share in 2024.

Why do Hospitals Dominate the Intracranial Pressure (ICP) Monitoring Market?

“Increasing Number of Patients with Traumatic Brain Injuries in Hospitals”

Attibute	Detail
Market Share in 2024	24.8%

The hospital segment is expected to hold 24.8% of the market share by product type in 2024. The segment is expected to register a CAGR of 4.5% through 2034.

Hospitals are the leading end users of intracranial pressure monitoring devices, accounting for a significant share of the global market. This can be attributed to the increasing number of patients with neurological disorders and traumatic brain injuries who require ICP monitoring in hospital settings. Additionally, the availability of skilled healthcare professionals and advanced healthcare infrastructure in hospitals further contributes to the growth of this segment. The hospital segment includes both public and private hospitals, and the demand for ICP monitoring devices is expected to continue to rise in both types of facilities.

Competitive Landscape

The competitive landscape for the intracranial pressure monitoring market is quite diverse and constantly evolving. These companies offer a variety of products and services related to intracranial pressure monitoring, including devices, software, and accessories. Other factors that contribute to the competitive landscape of this market include pricing, product quality, customer service, and innovation.

Some of the prominent companies in the market are Sophysa Ltd., Spiegelberg, Integra LifeSciences, HeadSense Medical, Medtronic, Raumedic, Johnson and Johnson, and Vittamed.

Notable Development

• In 2019, Raumedic introduced the Raumed home intracranial pressure monitoring system for use at home. This provides neurosurgeons with additional therapeutic options and enables people with hydrocephalus to enjoy more active lifestyles.

Segmentation of Intracranial Pressure (ICP) Monitoring Market Research

• By Product Type :

  • ICP Monitoring
  • Accessories

• By Route of Intervention :

  • Intraventricular
  • Subdural
  • Epidural
  • Parenchymal
  • Subarachnoid

• By Indication :

  • Traumatic Brain Injury
  • Intracerebral Hemorrhage
  • Subarachnoid hemorrhage
  • Hydrocephalus
  • Malignant Cerebral Infarction (MCI)
  • Cerebral Edema
  • CNS infections
  • Others

• By End User :

  • Hospitals
  • Ambulatory Surgical Centers
  • Trauma Centers
  • Neurosurgery Centers

• By Region :

  • North America
  • Europe
  • Latin America
  • East Asia
  • South Asia & Oceania
  • Middle East & Africa